4.2.2 Antipsychotic depot injections
Aripiprazole
Aripiprazole 400mg powder and solvent for suspension for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Central nervous system | Schizophrenia |
Aripiprazole 400mg powder and solvent for suspension for injection vials
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Central nervous system | Schizophrenia |
Flupentixol decanoate
Flupentixol 100mg/1ml solution for injection ampoules
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Central nervous system | Schizophrenia |
Flupentixol 200mg/1ml solution for injection ampoules
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Central nervous system | Schizophrenia |
Flupentixol 20mg/1ml solution for injection ampoules
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Central nervous system | Schizophrenia |
Haloperidol decanoate
Haloperidol decanoate 100mg/1ml solution for injection ampoules
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Central nervous system | Schizophrenia |
Haloperidol decanoate 50mg/1ml solution for injection ampoules
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Central nervous system | Schizophrenia |
Paliperidone
Byannli 1000mg/5ml prolonged-release suspension for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Central nervous system | Schizophrenia |
Byannli 700mg/3.5ml prolonged-release suspension for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Central nervous system | Schizophrenia |
Paliperidone 100mg/1ml prolonged-release suspension for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Central nervous system | Schizophrenia |
Paliperidone 150mg/1.5ml prolonged-release suspension for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Central nervous system | Schizophrenia |
Paliperidone 50mg/0.5ml prolonged-release suspension for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Central nervous system | Schizophrenia |
Paliperidone 75mg/0.75ml prolonged-release suspension for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Central nervous system | Schizophrenia |
Trevicta 175mg/0.875ml prolonged-release suspension for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Central nervous system | Schizophrenia |
Trevicta 263mg/1.315ml prolonged-release suspension for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Central nervous system | Schizophrenia |
Trevicta 350mg/1.75ml prolonged-release suspension for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Central nervous system | Schizophrenia |
Trevicta 525mg/2.625ml prolonged-release suspension for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Central nervous system | Schizophrenia |
Zuclopenthixol decanoate
Zuclopenthixol decanoate 200mg/1ml solution for injection ampoules
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Central nervous system | Schizophrenia |
Zuclopenthixol decanoate 500mg/1ml solution for injection ampoules
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Central nervous system | Schizophrenia |